Solvias

Kaiseraugst, Switzerland Founded: 1999 • Age: 27 yrs Acquired By Water Street
Integrated RD services are provided for pharmaceuticals and allied sectors.

About Solvias

Solvias is a Healthcare company based in Kaiseraugst (Switzerland) founded in 1999, and was acquired by Water Street in June 2020. Integrated RD services are provided for pharmaceuticals and allied sectors. Solvias has completed 2 acquisitions, including Cergentis and Chemic Laboratories. Its website solvias.com draws about 13 thousand monthly visits. Solvias offers products and services including Analytical Method Development, cGMP Drug Testing, Stability Testing, and Extractables and Leachables Testing. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its legal entity is Solvias AG.

Company details

Solvias is offering integrated research and development services across the drug development services for the pharma and biotech and a range of other industries such as medical devices, cosmetics, agrochemicals, chemicals, and electronic materials. They have capabilities for offering analytical services, small molecule analysis, biopharmaceutical analysis, solid-state development, catalysis technology, custom synthesis manufacturing. Their service portfolio includes physicochemical characterization, comparability studies, methods development and validation, raw material testing, product release testing, stability storagetesting, cell-based bioassays, etc.

  • Headquarters Kaiseraugst, Switzerland
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website solvias.com
  • Social LinkedIn Facebook YouTube
  • Acquired by Water Street (Jun 2020)
  • Legal Name Solvias Ag
Key Metrics

Products & Services of Solvias

Solvias offers a comprehensive portfolio of products and services, including Analytical Method Development, cGMP Drug Testing, Stability Testing, and Extractables and Leachables Testing.

Analytical Method Development
Testing Service

Develops and validates methods for pharmaceutical analysis and quality control

cGMP Drug Testing
Compliance Service

Conducts testing and release for drug substances and products

Stability Testing
Quality Service

Evaluates product stability under various conditions

Extractables and Leachables Testing
Safety Service

Assesses impurities and contamination in materials

Apps and channels of Solvias

its YouTube channel Solvias AG has 23 subscribers and 30 videos.

Solvias AG
YouTube 23 subscribers 30 videos Science & Technology
Open channel

Videos from Solvias

The most watched videos on Solvias's YouTube channel, Solvias AG (23 subscribers). Click a video to play it here.

Webinar: Accurate Vector Copy Number VCN determination in Gene Modified Cellular Products
309 views
Navigating Complexity: Tailoring Cell Based Bioassays for Advanced Therapeutics
142 views
Strategies for Determining Critical Quality Attributes of Nucleic Acid Therapeutics & Their Carriers
123 views
Webinar: Biopharmaceuticals, Cell & Gene Therapy. Single-Use Technology and Extractable/Leachables:
123 views

More on Solvias AG.

Funding Insights of Solvias

  • Total Rounds 6
  • Last Round Grant β€” $172,475
  • First Round $64,355

    (Jul 2015)

  • Investors Count 2

All 6 funding rounds of Solvias with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2021$172,475Grant––
Feb 2020Private Equity Round–Water Street
–
Jan 2018$1.56MGrant––
Feb 2017$12Grant––
Feb 2016$32,476Grant––
Jul 2015$64,355Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Solvias

Solvias has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Water Street and JLL Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Water Street is engaged in strategic investments in healthcare sectors.
2005waterstreet.comChicago, United States
JLL Partners is engaged in middle-market business transformation and investment.
jllpartners.comNew York, United States
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Solvias

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Solvias

110 people are tracked at Solvias (28 in leadership, 82 in team).

NameRoleGroup
Norberto Bonalumi
Head Of Business DevelopmentLeadership
Emine Sakka
Lab Head Capillary ElectrophoresisLeadership
Lars Leuenberger
Head Operation Probes DepartmentLeadership
Archie Cullen
Chief Executive OfficerLeadership
Daniel Galbraith
Chief Science OfficerLeadership
Marco Sacher
Department Head Chromatography Services And Validation Small MoleculesLeadership
Roger Fischler
Head Operations Chromatography Small Molecule ServicesLeadership
Debora Zamuner
HR Business PartnerLeadership
Saskia Suter
Head HRLeadership
Florian Bächle
Head Of Operations Product & Manufacturing ServicesLeadership
Amale Labrahmi
Head Of Group StrategyLeadership
Tim Jodszuweit
Group Head Supply ChainLeadership
Ray Sexton
Strategic Business PartnerLeadership
Rafael Sande
Senior Director Operations, Bioanalysis CharacterizationLeadership
Juergen Rotzler
Vice President, Operational Development ServicesLeadership
Christoph Lederer
Head Operations Separation & Elisa; Large Molecules & ATMPLeadership
Franck Auert
Operations Head Pharmaceutical AnalysisLeadership
Alison Gerhardt
Head Of Microbiology LaboratoryLeadership
Georgios Georgiou
Global Head Of IT Operations And Lab ITLeadership
Tabea Zubel
Lab Head Biological Mass SpectrometryLeadership

90 more people are available in the full profile.

Premium access

Complete people profiles for Solvias

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Solvias

Solvias has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cergentis and Chemic Laboratories.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Kits and services for targeted gene sequencing are provided.
cergentis.comUtrecht, Netherlands2012Jul 2022β€’β€’β€’β€’
Contract chemistry organization offering cGMP analytical testing, small scale cGMP manufacturing and synthetic chemistry services
chemiclabs.comCanton, United States1998Jun 2021β€’β€’β€’β€’
Premium access

Complete acquisition details for Solvias

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Solvias

6 dated milestones of Solvias across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded Solvias is founded.
  2. Funding First funding round of $64K.
  3. Exit Acquired by Water Street.
  4. Funding Latest funding round, Grant, of $172K.
  5. Acquisition Acquires Chemic Laboratories.
  6. Acquisition Acquires Cergentis.

Web traffic of Solvias

The website of Solvias (solvias.com) receives about 13.4K visits a month.

  • Monthly visits
    13.4K

    ▼ 21.3% vs previous month

Similar websites

Websites whose visitors overlap most with Solvias. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
qcal.de
qcal.de
100%
–
ftu.at
ftu.at
100%
–
restekgmbh.de
restekgmbh.de
100%
–
laborluedemann.de
laborluedemann.de
100%
–
schumann-analytics.de
schumann-analytics.de
100%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 24 similar websites and full traffic analytics for Solvias

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 24 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Solvias

Premium access

Complete news archive for Solvias

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Solvias

Solvias was founded in 1999 and raised its 1st funding round 16 years after it was founded.

Solvias is headquartered in Kaiseraugst, Switzerland. It is registered at Kaiseraugst, Aargau, Switzerland.

Solvias is offering integrated research and development services across the drug development services for the pharma and biotech and a range of other industries such as medical devices, cosmetics, agrochemicals, chemicals, and electronic materials. They have capabilities for offering analytical services, small molecule analysis, biopharmaceutical analysis, solid-state development, catalysis technology, custom synthesis manufacturing. Their service portfolio includes physicochemical characterization, comparability studies, methods development and validation, raw material testing, product release testing, stability storagetesting, cell-based bioassays, etc.

Solvias offers Analytical Method Development, cGMP Drug Testing, Stability Testing, and Extractables and Leachables Testing.

Solvias has made 2 acquisitions, including Cergentis, and Chemic Laboratories.

Solvias has 3 investors. Key investors include European Union, Water Street, and JLL Partners.

Solvias operates through Solvias Ag.

Yes. Solvias was acquired by Water Street in June 2020.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available